J. Roenn

发表

Chapter 50 – What Is the Relationship Between Patient Performance Status and Ability to Offer Chemotherapeutic Treatments?

K. Ramchandran, J. Roenn, 2013 .

Clinical presentations and standard therapy of AIDS-associated Kaposi's sarcoma.

J. Roenn, 2003 .

End-of-Life Care in Patients with Lung Cancer

J. Roenn, J. Brandman, 2004 .

Principles and Practice of Palliative Care and Supportive Oncology

J. Shuster, A. Berger, J. Roenn, 2002 .

Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer

R. Theriault, B. Hillner, W. Barlow, 2011 .

American Society of Clinical Oncology Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer

R. Theriault, B. Hillner, W. Barlow, 2011 .

Advance care planning: ensuring that the patient's voice is heard.

J. Roenn, 2013 .

Palliative Care for Interventional Radiology: An Oncologist's Perspective.

T. Campbell, J. Roenn, 2007, Seminars in interventional radiology.

Chapter 48 – What Is the Role for Palliative Care in Patients With Advanced Cancer?

K. Ramchandran, J. Roenn, 2013 .

Treatment of Kaposis Sarcoma

M. Cianfrocca, J. Roenn, 2001 .

PHASE II TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, & ETOPOSIDE (CDE) IN HIV-ASSOCIATED NON-HODGKIN'S LYMPHOMA (NHL): AN EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) TRIAL (E1494).

J. Sparano, R. Ambinder, D. Henry, 1999 .

Pertussis and Pertussis Vaccines in Adults

L. Ratner, M. Testa, L. Kaplan, 2016 .

Chapter 25 – Hematology/Oncology

T. Campbell, J. Roenn, 2011 .

Barriers to Pain Control: Ethics & Knowledge:

C. Gunten, J. Roenn, 1994 .

Interferon-α2b With Protease Inhibitor-Based Antiretroviral Therapy in Patients With AIDS-Associated Kaposi Sarcoma: An AIDS Malignancy Consortium Phase I Trial

M. Fischl, Jeannette Y Lee, R. Ambinder, 2006, Journal of acquired immune deficiency syndromes.

Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)

N. Hansen, W. Gradishar, A. Gutin, 2015, Breast Cancer Research and Treatment.

Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi’s sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial

J. Sparano, M. Rudek, B. Dezube, 2011, Cancer Chemotherapy and Pharmacology.

Highlights in metastatic breast cancer From the 2012 San Antonio Breast Cancer Symposium (SABCS).

S. Khan, S. Rosen, J. Roenn, 2013, Clinical advances in hematology & oncology : H&O.

Can an item response theory-based pain item bank enhance measurement precision?

D. Cella, J. Roenn, K. Dineen, 2003 .

Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib

N. Hansen, D. Scholtens, W. Gradishar, 2012, Breast Cancer Research and Treatment.

Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer

R. Theriault, B. Hillner, W. Barlow, 2013 .

Re-validation and Shortening of the Functional Assessmentof Anorexia/Cachexia Therapy (FAACT) Questionnaire

D. Cella, E. Hahn, N. S. Tchekmedyian, 2004, Quality of Life Research.

Therapeutic Options for HIV-Associated Bodyweight Loss

V. Stosor, J. Roenn, 1997, Drug safety.

NCCN Palliative Care Panel Members

C. Benedetti, S. Block, D. Spiegel, 2010 .

Development and validation of eleven symptom indexes to evaluate response to chemotherapy for advanced cancer: Measurement compliance with regulatory demands

A. Abernethy, D. Cella, S. Yount, 2007 .

KAPOSI'S SARCOMA RESPONSE CRITERIA: ISSUES IDENTIFIED BY THE NATIONAL CANCER INSTITUTE, FOOD AND DRUG ADMINISTRATION, AND THE AIDS MALIGNANCY CONSORTIUM

R. Wittes, S. Arbuck, A. Murgo, 1997 .

A Phase I Trial of a Pegylated Liposomal Anthracycline (DoxilTM) and Lapatinib Combination in the Treatment of Metastatic Breast Cancer: Dose-Escalation Results of an Anthracycline and Lapatinib Combination Trial.

A. Rademaker, W. Gradishar, S. Rubin, 2009 .

Human immunodeficiency virus and palliative care

R. Hirschtick, J. Roenn, 2009 .

Chapter 1 – Hematology/Oncology

T. Campbell, J. H. Roenn, J. Roenn, 2007 .

Are We Putting the Cart Before the Horse

C. Gunten, J. Roenn, 2009 .

Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.

J. V. Von Roenn, J. Coon, J. Wolter, 1986, Cancer research.

Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants.

J. V. Von Roenn, M. Testa, J. Huang, 1999, Journal of acquired immune deficiency syndromes.

Implementation of supportive care and best supportive care interventions in clinical trials enrolling patients with cancer†.

K. Ramchandran, T. Sanft, J. Roenn, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcoma.

J. V. Von Roenn, R. Golub, S. Stewart, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men.

J. V. Von Roenn, D. Seminara, A. Saah, 1993, American journal of epidemiology.

A phase II study of the proteasome inhibitor PS-341 in patients (pts) with metastatic breast cancer (MBC).

A. Rademaker, S. Badve, R. O'Regan, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.

J. V. Von Roenn, J. Wolter, P. Bonomi, 1988, Seminars in oncology.

Are We the Barrier

J. Roenn, 2001 .

Pilot Neoadjuvant Trial with Combination of Lapatinib and Nab-Paclitaxel in HER2+ Breast Cancer.

N. Hansen, W. Gradishar, J. Jeruss, 2009 .